logo

For the Inventor, By the Inventor

Warsaw, IN, United States of America

Biomet Biologics, LLC

USPTO Granted Patents = 118

% Expired Patents = 32.2



Trademarks = 7

Forward Citations = 2,728

Loading Chart...
Loading Chart...

37 inventors (with patents filed for the assignee):

goldMedal Michael D Leach (64 out of 91 patents)

silverMedal Joel C Higgins (34 out of 48 patents)

bronzeMedal Jennifer E Woodell-May (32 out of 41 patents)

4.  Randel E Dorian (25 out of 35 patents)

5.  Jason M Chavarria (17 out of 46 patents)

6.  Jacy C Hoeppner (17 out of 52 patents)

7.  Richard Wood Storrs (11 out of 33 patents)

8.  Matthew D Landrigan (11 out of 12 patents)

9.  Alan David Gray (9 out of 10 patents)

10.  Ned M Hamman (8 out of 13 patents)

11.  Matthew Swift (8 out of 15 patents)

12.  James M McKale (8 out of 11 patents)

13.  Barry F Hecker (7 out of 11 patents)

14.  Brandon Miller (6 out of 9 patents)

15.  William King (5 out of 22 patents)


Core Competencies:
Macrophage Phenotypes
Red Blood Cells
Cell Washing
Protein Solutions
Interleukin-1
Fluid Separation
Acellular Compositions
Thrombin
Angiogenesis
Surgical Mesh
Centrifugal Force
Biological Solutions

118 patents:

1. 10946043 - Methods of mediating macrophage phenotypes (2021-03-16),
2. 10898520 - Methods for rejuvinating red blood cells (2021-01-26),
3. 10821218 - Cell washing using acoustic waves (2020-11-03),
4. 10737012 - Cell washing using acoustic waves (2020-08-11),
5. 10441635 - Methods of treating pain using protein solutions (2019-10-15),
6. 10441634 - Treatment of peripheral vascular disease using protein solutions (2019-10-15),
7. 10400017 - Methods and compositions for delivering interleukin-1 receptor antagonist (2019-09-03),
8. 10393728 - Apparatus and method for separating and concentrating fluids containing multiple components (2019-08-27),
9. 10106587 - Methods and compositions for delivering interleukin-1 receptor antagonist (2018-10-23),
10. 10036006 - Cell washing device using a wave (2018-07-31),
11. 9968870 - Cell washing device using a bulk acoustic wave with phantom material (2018-05-15),
12. 9963693 - Cell washing device using a wave (2018-05-08),
13. 9950035 - Methods and non-immunogenic compositions for treating inflammatory disorders (2018-04-24),
14. 9950012 - Methods for rejuvenating red blood cells (2018-04-24),
15. 9937445 - System and method for separating a fraction (2018-04-10),
Company Overview
Biomet Biologics, LLC, based in Warsaw, Indiana, specializes in advanced cell separation technologies. The company focuses on the development and manufacturing of innovative solutions that enhance the processing of biological materials, particularly in the context of macrophage phenotypes and red blood cells. Their expertise extends to fluid separation and acellular compositions, providing critical advancements in medical applications. Biomet Biologics is committed to improving patient outcomes through its cutting-edge protein solutions and cell washing techniques.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Biomet Biologics, LLC USPTO Patent Assignee Logo
118 Patents

#8 in Warsaw, IN

#61 in Indiana

#3,269 in US

#6,746 in the World

Warsaw, IN (US)
Warsaw, IN, United States of America

Biomet Biologics, LLC

Forward Citations = 2,728

37 inventors:

goldMedal Michael D Leach (64 out of 91 patents)

silverMedal Joel C Higgins (34 out of 48 patents)

bronzeMedal Jennifer E Woodell-May (32 out of 41 patents)

4.  Randel E Dorian (25 out of 35 patents)

5.  Jason M Chavarria (17 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomet Biologics, LLC. Retrieved from https://idiyas.com/company/biomet-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…